5.99

4.31% -0.27

After Hours: 5.99

Precision Biosciences Inc (DTIL)

Overview News Price History Option Chain Financials Discussions Forecast

Precision Biosciences Inc stock is traded at $5.99, with a volume of 417.79K. It is down -4.31% in the last 24 hours and up +29.93% over the past month. Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Previous Close:

$6.26

Open:

$6.42

24h Volume:

417.79K

Relative Volume:

1.55

Market Cap:

$148.11M

Revenue:

$34.26M

Net Income/Loss:

$-46.61M

P/E Ratio:

-1.1562

EPS:

-5.1806

Net Cash Flow:

$-62.01M

1W Performance:

+5.27%

1M Performance:

+29.93%

6M Performance:

+5.09%

1Y Performance:

+29.65%

1-Day Range:

$5.66

$6.50

1-Week Range:

$5.61

$6.50

52-Week Range:

$3.53

$8.82

Precision Biosciences Inc Stock (DTIL) Company Profile

Name

Precision Biosciences Inc

Sector

Healthcare (1111)

Industry

Biotechnology (624)

Phone

919-314-5512

Address

302 EAST PETTIGREW STREET, DURHAM, NC

Employee

Twitter

@PrecisionBioSci

Next Earnings Date

2026-03-12

Latest SEC Filings

DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DTIL Precision Biosciences Inc	5.99	154.79M	34.26M	-46.61M	-62.01M	-5.1806
VRTX Vertex Pharmaceuticals Inc	443.92	109.85B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	775.53	80.38B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	785.07	47.60B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	327.25	42.63B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	312.19	33.72B	5.36B	287.73M	924.18M	2.5229

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	BMO Capital Markets	Market Perform → Outperform
Apr-30-24	Initiated	Guggenheim	Buy
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-09-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-27-20	Resumed	BTIG Research	Buy
Apr-03-20	Downgrade	Goldman	Buy → Neutral
Mar-05-20	Initiated	Stifel	Buy
Feb-25-20	Initiated	William Blair	Outperform
Aug-09-19	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	H.C. Wainwright	Buy
Apr-22-19	Initiated	Barclays	Overweight
Apr-22-19	Initiated	Goldman	Buy
Apr-22-19	Initiated	JP Morgan	Overweight
Apr-22-19	Initiated	Jefferies	Buy

View All

Precision Biosciences Inc Stock (DTIL) Latest News

10:55 AM

Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference - BioSpace

10:55 AM

07:01 AM

Gene-editing company Precision BioSciences presents at Needham on April 14 - Stock Titan

07:01 AM

07:00 AM

Precision BioSciences (NASDAQ: DTIL) details equity plan, charter change in 2026 proxy - Stock Titan

07:00 AM

Apr 04, 2026

Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 04, 2026

Apr 02, 2026

DTIL Stock Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Apr 02, 2026

Mar 31, 2026

DTIL Stock Price, Quote & Chart | PRECISION BIOSCIENCES INC (NASDAQ:DTIL) - ChartMill

Mar 31, 2026

Mar 30, 2026

Precision Biosciences Shares Face Significant Pressure Amid Market Skepticism () - aktiencheck.de

Mar 30, 2026

Quarterly Recap: What is the long term forecast for Precision BioSciences Inc stockExit Point & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 30, 2026

Mar 28, 2026

FOMO Trade: How does Precision BioSciences Inc perform in inflationary periodsPortfolio Return Report & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 28, 2026

Aug Action: Is Precision BioSciences Inc stock trending bullishInsider Buying & Expert Curated Trade Ideas - baoquankhu1.vn

Mar 28, 2026

Mar 27, 2026

3.8M-share increase, director elections and charter change at Precision BioSciences (NASDAQ: DTIL) - Stock Titan

Mar 27, 2026

Mar 26, 2026

Will Precision BioSciences Inc be affected by tariffs2026 Biggest Moves & Growth Focused Entry Point Reports - baoquankhu1.vn

Mar 26, 2026

VIX Spike: How does Precision BioSciences Inc compare to its peersQuarterly Risk Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Decliners Report: Is Rafael Holdings Inc Equity Warrant stock a good dividend stockProduct Launch & Safe Swing Trade Setups - baoquankhu1.vn

Mar 25, 2026

Precision BioSciences (DTIL) surpasses Q4 earnings and revenue estimates - MSN

Mar 25, 2026

Mar 24, 2026

Meme Stocks: What is the PEG ratio of Precision BioSciences Inc2026 Opening Moves & Risk Managed Investment Strategies - baoquankhu1.vn

Mar 24, 2026

Precision BioSciences (DTIL) Expected to Announce Earnings on Tuesday - MarketBeat

Mar 24, 2026

Mar 23, 2026

Q1 EPS Estimate for Precision BioSciences Raised by Analyst - MarketBeat

Mar 23, 2026

Mar 21, 2026

If You Invested $1,000 in Precision Biosciences (DTIL) - Stock Titan

Mar 21, 2026

Growth Value: How does Precision BioSciences Inc compare to its peers2026 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Brokers Set Expectations for DTIL Q1 Earnings - MarketBeat

Mar 20, 2026

ETFs Investing in Precision BioSciences, Inc. Stocks - TradingView

Mar 20, 2026

Mar 18, 2026

Portfolio Recap: Is Precision BioSciences Inc likely to announce a buybackTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn

Mar 18, 2026